<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4084291</article-id><article-id pub-id-type="publisher-id">cc7569</article-id><article-id pub-id-type="doi">10.1186/cc7569</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicenter randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Jabre</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Combes</surname><given-names>X</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Ricard-Hibon</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Mirat</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Cibien</surname><given-names>JF</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Bourzeix</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Dahouadi</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Adnet</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I7">7</xref></contrib></contrib-group><aff id="I1"><label>1</label>Mondor Hospital, Cr&#x000e9;teil, France</aff><aff id="I2"><label>2</label>Beaujon Hospital, Clichy, France</aff><aff id="I3"><label>3</label>Necker Hospital, Paris, France</aff><aff id="I4"><label>4</label>Montauban Hospital, Montauban, France</aff><aff id="I5"><label>5</label>Nancy Hospital, Nancy, France</aff><aff id="I6"><label>6</label>Nimes Hospital, Nimes, France</aff><aff id="I7"><label>7</label>Avicenne Hospital, Bobigny, France</aff><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>13</day><month>3</month><year>2009</year></pub-date><volume>13</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">29th International Symposium on Intensive Care and Emergency Medicine</named-content><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/supplements/notes/ccv13s1-info.pdf">http://ccforum.com/supplements/notes/ccv13s1-info.pdf</ext-link></supplement><fpage>P405</fpage><lpage>P405</lpage><permissions><copyright-statement>Copyright &#x000a9; 2009 Jabre et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Jabre et al; licensee BioMed Central Ltd.</copyright-holder></permissions><self-uri xlink:href="http://ccforum.com/content/13/S1/P405"/><conference><conf-date>24-27 March 2009</conf-date><conf-name>29th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Critically ill patients often require emergency intubation with administration of etomidate as the sedative agent. The use of etomidate has been challenged as it causes a reversible adrenal insufficiency probably leading to an increase in hospital morbidity.</p></sec><sec sec-type="methods"><title>Methods</title><p>In this prospective, randomized, controlled, single-blind trial, we assigned 234 patients to receive 0.3 mg/kg etomidate and 235 patients to receive 2 mg/kg ketamine for intubation. The primary endpoint was the maximum value of the Sequential Organ Failure Assessment score (SOFA<sub>max</sub>) during the first inhospital 3 days. (ClinicalTrials.gov number, NCT00440102.)</p></sec><sec sec-type="results"><title>Results</title><p>The mean SOFA<sub>max </sub>score between the two groups was not significantly different (10.3 &#x000b1; 3.7 for etomidate vs. 9.6 &#x000b1; 3.9 for ketamine; <italic>P </italic>= 0.056). There was no significant difference in 28-day mortality (81 (35%) deaths vs. 72 (31%) deaths, <italic>P </italic>= 0.36), the number of patients needing catecholamine (137 (59%) patients vs. 120 (51%) patients, <italic>P </italic>= 0.10), median (IQR) ventilator-free days (12 (0 to 25) days vs. 15 (0 to 26) days, <italic>P </italic>= 0.36) and median (IQR) hospital-free days (4 (0 to 22) days vs. 6 (0 to 23) days, <italic>P </italic>= 0.57). Adrenal insufficiency incidence was significantly higher in etomidate than ketamine group (86% vs. 48%, <italic>P </italic>&#x0003c; 0.001). There was no significant difference between the two groups in intubation conditions. There was no significant difference in outcome between the etomidate and ketamine groups on prespecified subgroup analysis (trauma or sepsis patients).</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Our results do not provide evidence for contra-indicating etomidate during emergency intubation in critically ill patients. However, ketamine can constitute a good alternative.</p></sec></body></article>